Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
15.77
+0.30 (1.94%)
Mar 9, 2026, 3:56 PM EDT - Market open
Erasca Market Cap
Erasca has a market cap or net worth of $4.88 billion as of March 9, 2026. Its market cap has increased by 1,082.75% in one year.
Market Cap
4.88B
Enterprise Value
4.38B
1-Year Change
1,082.75%
Ranking
Category
Stock Price
$15.77
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $4.88B, an increase of 162.72%. That is a compound annual growth rate of 23.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.79B | 353.79% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 5.42B |
| Celcuity | 5.32B |
| Caris Life Sciences | 5.25B |
| CG Oncology | 5.22B |
| Mirum Pharmaceuticals | 5.21B |
| Scholar Rock Holding | 5.20B |
| PTC Therapeutics | 5.20B |
| Apogee Therapeutics | 5.03B |